Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04475068
Other study ID # HNEdgardoRebagliatiMartins
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 17, 2020
Est. completion date October 31, 2020

Study information

Verified date August 2021
Source Hospital Nacional Edgardo Rebagliati Martins
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to evaluate if a postural recruitment maneuver (PRM) improves the aeration and distribution of lung ventilation in patients with Acute Respiratory Distress Syndrome (ARDS) caused by COVID-19 infection; without the need to reach high airway pressures as in the standard lung recruitment maneuver and / or place the patient in prone position. This strategy could be particularly useful in the context of a major health emergency in centers with limited resources.


Description:

The PRM is based on the known effect of gravity on transpulmonary pressure (PL). Two principles explain its mechanism of action: 1) the first indicates that atelectasis and poorly ventilated areas of the lung can improve their aeration by putting the lung in the highest position. Opposite lateral decubitus causes that upper lung to have a higher PL and allow a recruiting effect at moderate airway pressures. 2) The second principle is based on Laplace's Law and postulates that once the upper lung is recruited, it remains without lung collapse if a sufficient level of positive end-expiratory pressure (PEEP) is applied. Based on these two precepts, PRM consists of sequentially moving the patient from the supine to the left lateral decubitus to recover the aeration of the right lung. After that, the patient is placed in the right lateral position to recruit the left lung; keeping the right lung without collapse by continuous use of PEEP. Finally, the patient returns to the supine position looking for an improvement in the distribution of ventilation and global pulmonary aeration, with a subsequent improvement in gas exchange and pulmonary mechanics.


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date October 31, 2020
Est. primary completion date September 30, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients > 18 years of age - Patients with moderate-to-severe ARDS as per the Berlin definition - Infection due to COVID-19 - Body mass index (BMI) = 35 kg /m^2. Exclusion Criteria: - Contraindication for EIT monitoring 1. Unstable spine or pelvic fractures 2. Pacemaker, automatic implantable cardioverter defibrillator 3. Skin lesions between the 4th and 5th ribs where the EIT belt is worn - Pregnancy - Major hemodynamic instability:: 1. Mean arterial pressure lower than 60 mm Hg despite adequate fluid resuscitation and use of vasopressors. 2. FC> 120 or <60 per minute 3. Presence of uncontrolled arrhythmias. - More than 1 week of mechanical ventilation - Failure of more than 2 extrapulmonary organs.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Lateral Position (left and right lateral decubitus)
Prior to initiating the protocol, patients will be sedated deeply with sedatives and opioids and paralyzed. Patients will be evaluated in 5 positions sequentially: 1) Supine 2) Left lateral 3) Supine 4) Right lateral 5) Supine. The side with the least ventilation evaluated by EIT will define which side will start the sequence. Each step will last 30 minutes. Aeration measured by Electric Impedance Tomography (EIT) and lung ultrasound, distribution of the lung ventilation and perfusion measured by EIT, ventilator and hemodynamic parameters, esophageal pressure, and blood gas analysis will be recorded at the end of each step. Continuous monitoring of blood pressure, heart rate and saturation of arterial blood (SpO2) will be carried out during all steps of the protocol to assess the tolerance to the procedure.

Locations

Country Name City State
Peru Hospital Rebagliati Jesús María Lima

Sponsors (2)

Lead Sponsor Collaborator
Hospital Nacional Edgardo Rebagliati Martins Universidad de Piura

Country where clinical trial is conducted

Peru, 

Outcome

Type Measure Description Time frame Safety issue
Primary Effects of a postural recruitment maneuver in lung aeration Lung aeration measured by ultrasound reaeration score, ranges from 0 (all regions are well aerated) to 36 (all regions are consolidated). Through study completion (up to 24 hours)
Primary Effects of a postural recruitment maneuver in distribution of ventilation Distribution of ventilation measured by EIT (distribution and changes in the impedance in AU, arbitray units) Through study completion (up to 24 hours)
Primary Effects of a postural recruitment maneuver in gas exchange Gas exchange measured by blood gas analysis (PaO2, PaCO2, in mmHg) and capnography (end-tidal CO2, in mmHg) Through study completion (up to 24 hours)
Primary Effects of a postural recruitment maneuver in respiratory mechanics Respiratory mechanics measured by esophageal balloon (esophageal pressure, transpulmonary pressure, in cmH2O) Through study completion (up to 24 hours)
Primary Effects of a postural recruitment maneuver in hemodynamic Hemodynamic data measured by invasive arterial monitoring (mean arterial pressure, in mmHg) Through study completion (up to 24 hours)
Secondary Feasibility of a postural recruitment maneuver Oxigenatory tolerance evaluated with pulse oximeter (arterial oxygen saturation, in percentage) Through study completion (up to 24 hours)
See also
  Status Clinical Trial Phase
Completed NCT04435613 - Clinical and Physiological Assessment of a Nearly Ultra-protective Lung Ventilation Strategy: A Quasi-experimental Preliminary Study in ARDS Patients N/A
Enrolling by invitation NCT05020210 - Effect of Early Treatment With Sivelestat Sodium in ARDS Patients
Completed NCT04468971 - REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia Phase 1
Completed NCT04505592 - Tenecteplase in Patients With COVID-19 Phase 2
Completed NCT04493242 - Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS Phase 2
Withdrawn NCT04909879 - Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome Phase 2
Completed NCT02265198 - Relationship of Pulmonary Contusion to Pulmonary Inflammation and Incidence of Acute Respiratory Distress Syndrome N/A
Completed NCT01949272 - Optimization of PEEP for Alveolar Recruitment in ARDS N/A
Not yet recruiting NCT01668368 - Goal Directed Mechanical Ventilation Aimed at Optimal Lung Compliance N/A
Completed NCT01881061 - Lung Sonography in Patients With Acute Respiratory Distress Syndrome in Intensive Care Unit N/A
Completed NCT00808691 - Microcirculation and Oxidative Stress in Critical Ill Patients in Surgical Intensive Care Unit N/A
Completed NCT05035589 - The Effect of Tocilizumab on Procalcitonin and Other Biochemical and Clinical Markers in the Setting of COVID-19 Pneumonia
Recruiting NCT04764032 - Right Ventricular Dysfunction in Ventilated Patients With COVID-19
Completed NCT04556513 - Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status
Recruiting NCT06036056 - NMR Based Metabolomics Kinetics in ARDS Patients
Recruiting NCT04503876 - Effects of End-expiratory Positive Pressure Optimization in Intubated Patients With Healthy Lung or Acute Respiratory Distress Syndrome N/A
Recruiting NCT04643691 - Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS Phase 2
Completed NCT04395911 - Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections N/A
Not yet recruiting NCT05341687 - Prognostic Value of Respiratory System Compliance Under VV-ECMO on 180-day Mortality in COVID-19 ARDS.
Recruiting NCT05056090 - Effect of Prone Positioning on Mortality in Patients With Mild to Moderate Acute Respiratory Distress Syndrome. N/A